Protein misfolding cyclic amplification (PMCA): Current status and future directions

Virus Research

Volumn 207, Issue , 2015, Pages 47-61

  Saá, Paula ^a   Cervenakova, Larisa ^a  

^a HOLLAND LABORATORY   (United States)

Author keywords

In vitro; Neurodegenerative diseases; Prions; Protein conformational disorders; Protein misfolding cyclic amplification; Transmissible spongiform encephalopathies

Indexed keywords

HEAT SHOCK PROTEIN 70; PRION; PROTEIN;

ARTICLE; BIOCHEMICAL ANALYSIS; CELL ISOLATION; CELL SIZE; CELL STRUCTURE; CONTAMINATION; EVOLUTION; EXOSOME; GENE AMPLIFICATION; HUMAN; IN VITRO STUDY; NONHUMAN; PLASMA; PRION; PRION DISEASE; PRIORITY JOURNAL; PROCESS OPTIMIZATION; PROTEIN MISFOLDING CYCLIC AMPLIFICATION; TECHNOLOGY; VIRUS REPLICATION; VIRUS STRAIN; ANIMAL; BIOCHEMISTRY; CHEMISTRY; GENETICS; METABOLISM; PROCEDURES; PROTEIN FOLDING; TRENDS;

ANIMALIA;

ANIMALS; BIOCHEMISTRY; HUMANS; PRION DISEASES; PRIONS; PROTEIN FOLDING; PROTEINS;

EID: 84938675373     PISSN: 01681702     EISSN: 18727492     Source Type: Journal    
DOI: 10.1016/j.virusres.2014.11.007     Document Type: Article

References (179)

1. Abdallah A., Wang P., Richt J.A., Sreevatsan S. Y145Stop is sufficient to induce de novo generation prions using protein misfolding cyclic amplification. Prion 2012, 6(1).
2. Akimov S., Vasilyeva I., Yakovleva O., McKenzie C., Cervenakova L. Murine bone marrow stromal cell culture with features of mesenchymal stem cells susceptible to mouse-adapted human TSE agent, Fukuoka-1. Folia neuropathologica/Association of Polish Neuropathologists and Medical Research Centre. Pol. Acad. Sci. 2009, 47(2):205-214.
3. Akimov S., Yakovleva O., Vasilyeva I., McKenzie C., Cervenakova L. Persistent propagation of variant Creutzfeldt-Jakob disease agent in murine spleen stromal cell culture with features of mesenchymal stem cells. J. Virol. 2008, 82(21):10959-10962.
4. Alais S., Simoes S., Baas D., Lehmann S., Raposo G., Darlix J.L., Leblanc P. Mouse neuroblastoma cells release prion infectivity associated with exosomal vesicles. Biol. Cell/under the auspices of the Eur. Cell Biol. Organ. 2008, 100(10):603-615.
5. Atarashi R., Moore R.A., Sim V.L., Hughson A.G., Dorward D.W., Onwubiko H.A., Priola S.A., Caughey B. Ultrasensitive detection of scrapie prion protein using seeded conversion of recombinant prion protein. Nat. Methods 2007, 4(8):645-650.
6. Atarashi R., Wilham J.M., Christensen L., Hughson A.G., Moore R.A., Johnson L.M., Onwubiko H.A., Priola S.A., Caughey B. Simplified ultrasensitive prion detection by recombinant PrP conversion with shaking. Nat. Methods 2008, 5(3):211-212.
7. Barret A., Tagliavini F., Forloni G., Bate C., Salmona M., Colombo L., De Luigi A., Limido L., Suardi S., Rossi G., Auvre F., Adjou K.T., Sales N., Williams A., Lasmezas C., Deslys J.P. Evaluation of quinacrine treatment for prion diseases. J. Virol. 2003, 77(15):8462-8469.
8. Barria M.A., Gonzalez-Romero D., Soto C. Cyclic amplification of prion protein misfolding. Methods Mol. Biol. 2012, 849:199-212.
9. Barria M.A., Mukherjee A., Gonzalez-Romero D., Morales R., Soto C. De novo generation of infectious prions in vitro produces a new disease phenotype. PLoS Pathog. 2009, 5(5):e1000421.
10. Barria M.A., Telling G.C., Gambetti P., Mastrianni J.A., Soto C. Generation of a new form of human PrP(Sc) in vitro by interspecies transmission from cervid prions. J. Biol. Chem. 2011, 286(9):7490-7495.
11. Belay E.D., Maddox R.A., Williams E.S., Miller M.W., Gambetti P., Schonberger L.B. Chronic wasting disease and potential transmission to humans. Emerg. Infect. Dis. 2004, 10(6):977-984.
12. Bennett A.D., Birkett C.R., Bostock C.J. Molecular biology of scrapie-like agents. Rev. Sci. Tech. 1992, 11(2):569-603.
13. Bessen R.A., Marsh R.F. Biochemical and physical properties of the prion protein from two strains of the transmissible mink encephalopathy agent. J. Virol. 1992, 66(4):2096-2101.
14. Bieschke J., Weber P., Sarafoff N., Beekes M., Giese A., Kretzschmar H. Autocatalytic self-propagation of misfolded prion protein. Proc. Natl. Acad. Sci. U. S. A. 2004, 101(33):12207-12211.
15. Boerner S., Wagenführ K., Daus M.L., Thomzig A., Beekes M. Towards further reduction and replacement of animal bioassays in prion research by cell and protein misfolding cyclic amplification assays. Lab. Anim. 2013, 47(2):106-115.
16. Bossers A., Belt P., Raymond G.J., Caughey B., de Vries R., Smits M.A. Scrapie susceptibility-linked polymorphisms modulate the in vitro conversion of sheep prion protein to protease-resistant forms. Proc. Natl. Acad. Sci. U. S. A. 1997, 94(10):4931-4936.
17. Braak H.B.E. Evolution of neuronal changes in the course of Alzheimer's disease. J. Neural Transm. Suppl. 1998, 53:127-140.
18. Brown P., Cervenáková L., McShane L.M., Barber P., Rubenstein R., Drohan W.N. Further studies of blood infectivity in an experimental model of transmissible spongiform encephalopathy, with an explanation of why blood components do not transmit Creutzfeldt-Jakob disease in humans. Transfusion 1999, 39(11):1169-1178.
19. Brown P., Rohwer R.G., Dunstan B.C., MacAuley C., Gajdusek D.C., Drohan W.N. The distribution of infectivity in blood components and plasma derivatives in experimental models of transmissible spongiform encephalopathy. Transfusion 1998, 38(9):810-816.
20. Bruce M.E. Scrapie strain variation and mutation. Br. Med. Bull. 1993, 49(4):822-838.
21. Bruce M.E., Will R.G., Ironside J.W., McConnell I., Drummond D., Suttie A., McCardle L., Chree A., Hope J., Birkett C., Cousens S., Fraser H., Bostock C.J. Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent. Nature 1997, 389(6650):498-501.
22. Budka H., Aguzzi A., Brown P., Brucher J.M., Bugiani O., Gullotta F., Haltia M., Hauw J.J., Ironside J.W., Jellinger K., et al. Neuropathological diagnostic criteria for Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (prion diseases). Brain Pathol. 1995, 5(4):459-466.
23. Castilla J., Gonzalez-Romero D., Saá P., Morales R., De Castro J., Soto C. Crossing the species barrier by PrP(Sc) replication in vitro generates unique infectious prions. Cell 2008, 134(5):757-768.
24. Castilla J., Morales R., Saá P., Barria M., Gambetti P., Soto C. Cell-free propagation of prion strains. EMBO J. 2008, 27(19):2557-2566.
25. Castilla J., Saá P., Hetz C., Soto C. In vitro generation of infectious scrapie prions. Cell 2005, 121(2):195-206.
26. Castilla J., Saá P., Morales R., Abid K., Maundrell K., Soto C. Protein misfolding cyclic amplification for diagnosis and prion propagation studies. Methods in Enzymology 2006, vol. 412:3-21. Academic Press.
27. Castilla J., Saá P., Soto C. Detection of prions in blood. Nat. Med. 2005, 11(9):982-985.
28. Castro-Seoane R., Hummerich H., Sweeting T., Tattum M.H., Linehan J.M., Fernandez de Marco M., Brandner S., Collinge J., Klohn P.C. Plasmacytoid dendritic cells sequester high prion titres at early stages of prion infection. PLoS Pathog. 2012, 8(2):e1002538.
29. Caughey B., Raymond G.J., Bessen R.A. Strain-dependent differences in beta-sheet conformations of abnormal prion protein. J. Biol. Chem. 1998, 273(48):32230-32235.
30. Cervenakova L., Akimov S., Vasilyeva I., Yakovleva O., McKenzie C., Cervenak J., Piccardo P., Asher D.M. Fukuoka-1 strain of transmissible spongiform encephalopathy agent infects murine bone marrow-derived cells with features of mesenchymal stem cells. Transfusion 2011, 51(8):1755-1768.
31. Cervenakova L., Yakovleva O., McKenzie C., Kolchinsky S., McShane L., Drohan W.N., Brown P. Similar levels of infectivity in the blood of mice infected with human-derived vCJD and GSS strains of transmissible spongiform encephalopathy. Transfusion 2003, 43(12):1687-1694.
32. Chen B., Morales R., Barria M.A., Soto C. Estimating prion concentration in fluids and tissues by quantitative PMCA. Nat. Methods 2010, 7(7):519-520.
33. Chianini F., Fernandez-Borges N., Vidal E., Gibbard L., Pintado B., de Castro J., Priola S.A., Hamilton S., Eaton S.L., Finlayson J., Pang Y., Steele P., Reid H.W., Dagleish M.P., Castilla J. Rabbits are not resistant to prion infection. Proc. Natl. Acad. Sci. U. S. A. 2012, 109(13):5080-5085.
34. Clarke M.C., Haig D.A. Evidence for the multiplication of scrapie agent in cell culture. Nature 1970, 225(5227):100-101.
35. Clarke M.C., Millson G.C. Infection of a cell line of mouse L fibroblasts with scrapie agent. Nature 1976, 261(5556):144-145.
36. Colby D.W., Giles K., Legname G., Wille H., Baskakov I.V., DeArmond S.J., Prusiner S.B. Design and construction of diverse mammalian prion strains. Proc. Natl. Acad. Sci. U. S. A. 2009, 106(48):20417-20422.
37. Colby D.W., Wain R., Baskakov I.V., Legname G., Palmer C.G., Nguyen H.O., Lemus A., Cohen F.E., DeArmond S.J., Prusiner S.B. Protease-sensitive synthetic prions. PLoS Pathog. 2010, 6(1):e1000736.
38. Coleman B.M., Hanssen E., Lawson V.A., Hill A.F. Prion-infected cells regulate the release of exosomes with distinct ultrastructural features. FASEB J.: Off. Publ. Fed. Am. Soc. Exp. Biol. 2012, 26(10):4160-4173.
39. Collinge J. Prion diseases of humans and animals: their causes and molecular basis. Ann. Rev. Neurosci. 2001, 24(1):519-550.
40. Collinge J., Whitfield J., McKintosh E., Beck J., Mead S., Thomas D.J., Alpers M.P. Kuru in the 21st century-an acquired human prion disease with very long incubation periods. Lancet 2006, 367(9528):2068-2074.
41. Cosseddu G.M., Nonno R., Vaccari G., Bucalossi C., Fernandez-Borges N., Di Bari M.A., Castilla J., Agrimi U. Ultra-efficient PrP(Sc) amplification highlights potentialities and pitfalls of PMCA technology. PLoS Pathog. 2011, 7(11):e1002370.
42. Couzin J. Biomedicine. An end to the prion debate? Don't count on it. Science 2004, 305(5684):589.
43. Daus M.L., Breyer J., Wagenfuehr K., Wemheuer W.M., Thomzig A., Schulz-Schaeffer W.J., Beekes M. Presence and seeding activity of pathological prion protein (PrP(TSE)) in skeletal muscles of white-tailed deer infected with chronic wasting disease. PloS ONE 2011, 6(4):e18345.
44. de Marco M.F., Linehan J., Gill O.N., Clewley J.P., Brandner S. Large-scale immunohistochemical examination for lymphoreticular prion protein in tonsil specimens collected in Britain. J. Pathol. 2010, 222(4):380-387.
45. Deleault N.R., Geoghegan J.C., Nishina K., Kascsak R., Williamson R.A., Supattapone S. Protease-resistant prion protein amplification reconstituted with partially purified substrates and synthetic polyanions. J. Biol. Chem. 2005, 280(29):26873-26879.
46. Deleault N.R., Harris B.T., Rees J.R., Supattapone S. Formation of native prions from minimal components in vitro. Proc. Natl. Acad. Sci. U. S. A. 2007, 104(23):9741-9746.
47. Deleault N.R., Kascsak R., Geoghegan J.C., Supattapone S. Species-dependent differences in cofactor utilization for formation of the protease-resistant prion protein in vitro. Biochemistry 2010, 49(18):3928-3934.
48. Deleault N.R., Lucassen R.W., Supattapone S. RNA molecules stimulate prion protein conversion. Nature 2003, 425(6959):717-720.
49. Deleault N.R., Piro J.R., Walsh D.J., Wang F., Ma J., Geoghegan J.C., Supattapone S. Isolation of phosphatidylethanolamine as a solitary cofactor for prion formation in the absence of nucleic acids. Proc. Natl. Acad. Sci. U. S. A. 2012, 109(22):8546-8551.
50. Deleault N.R., Walsh D.J., Piro J.R., Wang F., Wang X., Ma J., Rees J.R., Supattapone S. Cofactor molecules maintain infectious conformation and restrict strain properties in purified prions. Proc. Natl. Acad. Sci. U. S. A. 2012, 109(28):E1938-E1946.
51. Desplats P., Lee H.-J., Bae E.-J., Patrick C., Rockenstein E., Crews L., Spencer B., Masliah E., Lee S.-J. Inclusion formation and neuronal cell death through neuron-to-neuron transmission of α-synuclein. Proc. Natl. Acad. Sci. U. S. A. 2009, 106(31):13010-13015.
52. Di Bari M.A., Nonno R., Castilla J., D'Agostino C., Pirisinu L., Riccardi G., Conte M., Richt J., Kunkle R., Langeveld J., Vaccari G., Agrimi U. Chronic wasting disease in bank voles: characterisation of the shortest incubation time model for prion diseases. PLoS Pathog. 2013, 9(3):e1003219.
53. Dickinson A.G., Outram G.W., Taylor D.M., Foster J.D. Further evidence that scrapie agent has an independant genome. Unconventional Virus Diseases of the Central Nervous System (Paris 2-6 December 1986). CEA Diffusion 1989, 446-459. Fontenay-aux Roses, France. L.A. Court, D. Dormont, P. Brown, D.T. Kingsbury (Eds.).
54. Doi S., Ito M., Shinagawa M., Sato G., Isomura M., Goto H. Western blot detection of scrapie-associated fibril protein in tissues outside the central nervous system from preclinical scrapie-infected mice. J. Gen. Virol. 1988, 69:955-960.
55. Dragovic R.A., Gardiner C., Brooks A.S., Tannetta D.S., Ferguson D.J.P., Hole P., Carr B., Redman C.W.G., Harris A.L., Dobson P.J., Harrison P., Sargent I.L. Sizing and phenotyping of cellular vesicles using Nanoparticle Tracking Analysis. Nanomed.: Nanotechnol. Biol. Med. 2011, 7(6):780-788.
56. Fernandez-Borges N., de Castro J., Castilla J. In vitro studies of the transmission barrier. Prion 2009, 3(4):220-223.
57. Fevrier B., Vilette D., Archer F., Loew D., Faigle W., Vidal M., Laude H., Raposo G. Cells release prions in association with exosomes. Proc. Natl. Acad. Sci. U. S. A. 2004, 101(26):9683-9688.
58. Freundt E.C., Maynard N., Clancy E.K., Roy S., Bousset L., Sourigues Y., Covert M., Melki R., Kirkegaard K., Brahic M. Neuron-to-neuron transmission of α-synuclein fibrils through axonal transport. Ann. Neurol. 2012, 72(4):517-524.
59. Fujihara A., Atarashi R., Fuse T., Ubagai K., Nakagaki T., Yamaguchi N., Ishibashi D., Katamine S., Nishida N. Hyperefficient PrP Sc amplification of mouse-adapted BSE and scrapie strain by protein misfolding cyclic amplification technique. FEBS J. 2009, 276(10):2841-2848.
60. Gao C.M., Yam A.Y., Wang X., Magdangal E., Salisbury C., Peretz D., Zuckermann R.N., Connolly M.D., Hansson O., Minthon L., Zetterberg H., Blennow K., Fedynyshyn J.P., Allauzen S. Aβ40 oligomers identified as a potential biomarker for the diagnosis of Alzheimer's disease. PLoS ONE 2010, 5(12):e15725.
61. Geoghegan J.C., Valdes P.A., Orem N.R., Deleault N.R., Williamson R.A., Harris B.T., Supattapone S. Selective incorporation of polyanionic molecules into hamster prions. J. Biol. Chem. 2007, 282(50):36341-36353.
62. Georganopoulou D.G., Chang L., Nam J.-M., Thaxton C.S., Mufson E.J., Klein W.L., Mirkin C.A. Nanoparticle-based detection in cerebral spinal fluid of a soluble pathogenic biomarker for Alzheimer's disease. Proc. Natl. Acad. Sci. U. S. A. 2005, 102(7):2273-2276.
63. Gill O.N., Spencer Y., Richard-Loendt A., Kelly C., Dabaghian R., Boyes L., Linehan J., Simmons M., Webb P., Bellerby P., Andrews N., Hilton D.A., Ironside J.W., Beck J., Poulter M., Mead S., Brandner S. Prevalent abnormal prion protein in human appendixes after bovine spongiform encephalopathy epizootic: large scale survey. BMJ 2013, 347:f5675.
64. Giri R.K., Young R., Pitstick R., DeArmond S.J., Prusiner S.B., Carlson G.A. Prion infection of mouse neurospheres. Proc. Natl. Acad. Sci. U. S. A. 2006, 103(10):3875-3880.
65. Gonzalez-Montalban N., Makarava N., Savtchenko R., Baskakov I.V. Relationship between conformational stability and amplification efficiency of prions. Biochemistry 2011, 50(37):7933-7940.
66. Gonzalez-Romero D., Barria M.A., Leon P., Morales R., Soto C. Detection of infectious prions in urine. FEBS Lett. 2008, 582(21):3161-3166.
67. Gould S.J., Booth A.M., Hildreth J.E.K. The Trojan exosome hypothesis. Proc. Natl. Acad. Sci. U. S. A. 2003, 100(19):10592-10597.
68. Green K.M., Castilla J., Seward T.S., Napier D.L., Jewell J.E., Soto C., Telling G.C. Accelerated high fidelity prion amplification within and across prion species barriers. PLoS Pathog. 2008, 4(8):e1000139.
69. Haass C., Selkoe D.J. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid [beta]-peptide. Nat. Rev.: Mol. Cell Biol. 2007, 8(2):101-112.
70. Haley N.J., Mathiason C.K., Zabel M.D., Telling G.C., Hoover E.A. Detection of sub-clinical CWD infection in conventional test-negative deer long after oral exposure to urine and feces from CWD+ deer. PLoS ONE 2009, 4(11):e7990.
71. Haley N.J., Seelig D.M., Zabel M.D., Telling G.C., Hoover E.A. Detection of CWD prions in urine and saliva of deer by transgenic mouse bioassay. PLoS ONE 2009, 4(3):e4848.
72. Hamir A.N., Kehrli M.E., Kunkle R.A., Greenlee J.J., Nicholson E.M., Richt J.A., Miller J.M., Cutlip R.C. Experimental interspecies transmission studies of the transmissible spongiform encephalopathies to cattle: comparison to bovine spongiform encephalopathy in cattle. J. Vet. Diagn. Investig. 2011, 23(3):407-420.
73. Herva M.E., Zibaee S., Fraser G., Barker R.A., Goedert M., Spillantini M.G. Anti-amyloid compounds inhibit alpha-synuclein aggregation induced by Protein Misfolding Cyclic Amplification (PMCA). J. Biol. Chem. 2014.
74. Hilton D.A., Ghani A.C., Conyers L., Edwards P., McCardle L., Ritchie D., Penney M., Hegazy D., Ironside J.W. Prevalence of lymphoreticular prion protein accumulation in UK tissue samples. J. Pathol. 2004, 203(3):733-739.
75. Jarrett J.T., Lansbury P.T. Seeding one-dimensional crystallization of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie?. Cell 1993, 73(6):1055-1058.
76. Johnson C.J., Phillips K.E., Schramm P.T., McKenzie D., Aiken J.M., Pedersen J.A. Prions adhere to soil minerals and remain infectious. PLoS Pathog. 2006, 2(4):e32.
77. Jones M., Wight D., Barron R., Jeffrey M., Manson J., Prowse C., Ironside J.W., Head M.W. Molecular model of prion transmission to humans. Emerg. Infect. Dis. 2009, 15(12):2013-2016.
78. Kim H.J., Chatani E., Goto Y., Paik S.R. Seed-dependent accelerated fibrillation of alpha-synuclein induced by periodic ultrasonication treatment. Microbiol. Biotechnol. 2007, 17(12):2027-2032.
79. Kim J.I., Cali I., Surewicz K., Kong Q., Raymond G.J., Atarashi R., Race B., Qing L., Gambetti P., Caughey B., Surewicz W.K. Mammalian prions generated from bacterially expressed prion protein in the absence of any mammalian cofactors. J. Biol. Chem. 2010, 285(19):14083-14087.
80. Kimberlin R.H., Cole S., Walker C.A. Temporary and permanent modifications to a single strain of mouse scrapie on transmission to rats and hamsters. J. Gen. Virol. 1987, 68(Pt 7):1875-1881.
81. Klein W.L., Stine W.B., Teplow D.B. Small assemblies of unmodified amyloid β-protein are the proximate neurotoxin in Alzheimer's disease. Neurobiol. Aging 2004, 25(5):569-580.
82. Klingeborn M., Race B., Meade-White K.D., Chesebro B. Lower specific infectivity of protease-resistant prion protein generated in cell-free reactions. Proc. Natl. Acad. Sci. U. S. A. 2011, 108(48):E1244-E1253.
83. Klyubin I., Betts V., Welzel A.T., Blennow K., Zetterberg H., Wallin A., Lemere C.A., Cullen W.K., Peng Y., Wisniewski T., Selkoe D.J., Anwyl R., Walsh D.M., Rowan M.J. Amyloid β protein dimer-containing human CSF disrupts synaptic plasticity: prevention by systemic passive immunization. J. Neurosci. 2008, 28(16):4231-4237.
84. Knight R. The risk of transmitting prion disease by blood or plasma products. Transfus. Apheresis Sci. 2010, 43(3):387-391.
85. Kocisko D.A., Come J.H., Priola S.A., Chesebro B., Raymond G.J., Lansbury P.T., Caughey B. Cell-free formation of protease-resistant prion protein. Nature 1994, 370(6489):471-474.
86. Kocisko D.A., Priola S.A., Raymond G.J., Chesebro B., Lansbury P.T., Caughey B. Species specificity in the cell-free conversion of prion protein to protease-resistant forms: a model for the scrapie species barrier. Proc. Natl. Acad. Sci. U. S. A. 1995, 92(9):3923-3927.
87. Kong Q., Huang S., Zou W., Vanegas D., Wang M., Wu D., Yuan J., Zheng M., Bai H., Deng H., Chen K., Jenny A.L., O'Rourke K., Belay E.D., Schonberger L.B., Petersen R.B., Sy M.S., Chen S.G., Gambetti P. Chronic wasting disease of elk: transmissibility to humans examined by transgenic mouse models. J. Neurosci.: Off. J. Soc. Neurosci. 2005, 25(35):7944-7949.
88. Lacroux C., Comoy E., Moudjou M., Perret-Liaudet A., Lugan S., Litaise C., Simmons H., Jas-Duval C., Lantier I., Béringue V., Groschup M., Fichet G., Costes P., Streichenberger N., Lantier F., Deslys J.P., Vilette D., Andréoletti O. Preclinical detection of variant CJD and BSE prions in blood. PLoS Pathog. 2014, 10(6):e1004202.
89. Legname G., Baskakov I.V., Nguyen H.O., Riesner D., Cohen F.E., DeArmond S.J., Prusiner S.B. Synthetic mammalian prions. Science 2004, 305(5684):673-676.
90. Lucassen R., Nishina K., Supattapone S. In vitro amplification of protease-resistant prion protein requires free sulfhydryl groups. Biochemistry 2003, 42(14):4127-4135.
91. Luk K.C., Kehm V., Carroll J., Zhang B., O'Brien P., Trojanowski J.Q., Lee V.M.-Y. Pathological α-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice. Science 2012, 338(6109):949-953.
92. Luk K.C., Song C., O'Brien P., Stieber A., Branch J.R., Brunden K.R., Trojanowski J.Q., Lee V.M.-Y. Exogenous α-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells. Proc. Natl. Acad. Sci. U. S. A. 2009, 106(47):20051-20056.
93. Mahal S.P., Jablonski J., Suponitsky-Kroyter I., Oelschlegel A.M., Herva M.E., Oldstone M., Weissmann C. Propagation of RML prions in mice expressing PrP devoid of GPI anchor leads to formation of a novel, stable prion strain. PLoS Pathog. 2012, 8(6):e1002746.
94. Makarava N., Kovacs G.G., Bocharova O., Savtchenko R., Alexeeva I., Budka H., Rohwer R.G., Baskakov I.V. Recombinant prion protein induces a new transmissible prion disease in wild-type animals. Acta Neuropathol. 2010, 119(2):177-187.
95. Markovits P., Dautheville C., Dormont D., Dianoux L., Latarjet R. In vitro propagation of the scrapie agent. I. Transformation of mouse glia and neuroblastoma cells after infection with the mouse-adapted scrapie strain c-506. Acta Neuropathol. 1983, 60(1-2):75-80.
96. Mathiason C.K., Nalls A.V., Seelig D.M., Kraft S.L., Carnes K., Anderson K.R., Hayes-Klug J., Hoover E.A. Susceptibility of domestic cats to chronic wasting disease. J. Virol. 2013, 87(4):1947-1956.
97. Mathiason C.K., Powers J.G., Dahmes S.J., Osborn D.A., Miller K.V., Warren R.J., Mason G.L., Hays S.A., Hayes-Klug J., Seelig D.M., Wild M.A., Wolfe L.L., Spraker T.R., Miller M.W., Sigurdson C.J., Telling G.C., Hoover E.A. Infectious prions in the saliva and blood of deer with chronic wasting disease. Science 2006, 314(5796):133-136.
98. Mattei V., Barenco M.G., Tasciotti V., Garofalo T., Longo A., Boller K., Lower J., Misasi R., Montrasio F., Sorice M. Paracrine diffusion of PrP(C) and propagation of prion infectivity by plasma membrane-derived microvesicles. PLoS ONE 2009, 4(4):e5057.
99. Meyerett C., Michel B., Pulford B., Spraker T.R., Nichols T.A., Johnson T., Kurt T., Hoover E.A., Telling G.C., Zabel M.D. In vitro strain adaptation of CWD prions by serial protein misfolding cyclic amplification. Virology 2008, 382(2):267-276.
100. Milhavet O., Casanova D., Chevallier N., McKay R.D., Lehmann S. Neural stem cell model for prion propagation. Stem Cells 2006, 24(10):2284-2291.
101. Miller M.B., Wang D.W., Wang F., Noble G.P., Ma J., Woods V.L., Li S., Supattapone S. Cofactor molecules induce structural transformation during infectious prion formation. Structure 2013, 21(11):2061-2068.
102. Miller M.W., Williams E.S., Hobbs N.T., Wolfe L.L. Environmental sources of prion transmission in mule deer. Emerg. Infect. Dis. 2004, 10(6):1003-1006.
103. Moda F., Gambetti P., Notari S., Concha-Marambio L., Catania M., Park K.-W., Maderna E., Suardi S., Haïk S., Brandel J.-P., Ironside J., Knight R., Tagliavini F., Soto C. Prions in the urine of patients with variant Creutzfeldt-Jakob disease. N. Engl. J. Med. 2014, 371(6):530-539.
104. Morales R., Duran-Aniotz C., Diaz-Espinoza R., Camacho M.V., Soto C. Protein misfolding cyclic amplification of infectious prions. Nat. Protoc. 2012, 7(7):1397-1409.
105. Murayama Y., Yoshioka M., Okada H., Takata M., Yokoyama T., Mohri S. Urinary excretion and blood level of prions in scrapie-infected hamsters. J. Gen. Virol. 2007, 88(10):2890-2898.
106. Nguyen D.G., Booth A., Gould S.J., Hildreth J.E.K. Evidence that HIV budding in primary macrophages occurs through the exosome release pathway. J. Biol. Chem. 2003, 278(52):52347-52354.
107. Nichols T.A., Pulford B., Wyckoff A.C., Meyerett C., Michel B., Gertig K., Hoover E.A., Jewell J.E., Telling G.C., Zabel M.D. Detection of protease-resistant cervid prion protein in water from a CWD-endemic area. Prion 2009, 3(3):171-183.
108. Nichols T.A., Spraker T.R., Rigg T.D., Meyerett-Reid C., Hoover C., Michel B., Bian J., Hoover E., Gidlewski T., Balachandran A., O'Rourke K., Telling G.C., Bowen R., Zabel M.D., VerCauteren K.C. Intranasal inoculation of white-tailed deer (Odocoileus virginianus) with lyophilized chronic wasting disease prion particulate complexed to montmorillonite clay. PLoS ONE 2013, 8(5):e62455.
109. Nishina K., Deleault N.R., Lucassen R.W., Supattapone S. In vitro prion protein conversion in detergent-solubilized membranes. Biochemistry 2004, 43(9):2613-2621.
110. Pan K.M., Baldwin M., Nguyen J., Gasset M., Serban A., Groth D., Mehlhorn I., Huang Z., Fletterick R.J., Cohen F.E., Prusiner S.B. Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. Proc. Natl. Acad. Sci. U. S. A. 1993, 90:10962-10966.
111. Phillips G., Lopman B., Tam C., Iturriza-Gomara M., Brown D., Gray J. Diagnosing norovirus-associated infectious intestinal disease using viral load. BMC Infect. Dis. 2009, 9(1):63.
112. Phillips G., Lopman B., Tam C.C., Iturriza-Gomara M., Brown D., Gray J. Diagnosing rotavirus A associated IID: using ELISA to identify a cut-off for real time RT-PCR. J. Clin. Virol.: Off. Publ. Pan Am. Soc. Clin. Virol. 2009, 44(3):242-245.
113. Piro J.R., Harris B.T., Nishina K., Soto C., Morales R., Rees J.R., Supattapone S. Prion protein glycosylation is not required for strain-specific neurotropism. J. Virol. 2009, 83(11):5321-5328.
114. Piro J.R., Harris B.T., Supattapone S. In situ photodegradation of incorporated polyanion does not alter prion infectivity. PLoS Pathog. 2011, 7(2):e1002001.
115. Piro J.R., Supattapone S. Photodegradation illuminates the role of polyanions in prion infectivity. Prion 2011, 5(2):49-51.
116. Prusiner S.B. Novel proteinaceous infectious particles cause scrapie. Science 1982, 216(4542):136-144.
117. Prusiner S.B. Molecular biology of prion diseases. Science 1991, 252(5012):1515-1522.
118. Prusiner S.B. Cell biology. A unifying role for prions in neurodegenerative diseases. Science 2012, 336(6088):1511-1513.
119. Prusiner S.B., Safar J., DeArmond S.J. Bioassays of prions. Prion Biology and Diseases 2004, 143-186. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York. 2nd ed. S.B. Prusiner (Ed.).
120. Pulford B., Spraker T.R., Wyckoff A.C., Meyerett C., Bender H., Ferguson A., Wyatt B., Lockwood K., Powers J., Telling G.C., Wild M.A., Zabel M.D. Detection of PrPCWD in feces from naturally exposed Rocky Mountain elk (Cervus elaphus nelsoni) using protein misfolding cyclic amplification. J. Wildl. Dis. 2012, 48(2):425-434.
121. Race R., Meade-White K., Raines A., Raymond G.J., Caughey B., Chesebro B. Subclinical scrapie infection in a resistant species: persistence, replication, and adaptation of infectivity during four passages. J. Infect. Dis. 2002, 186(Suppl. 2):S166-S170.
122. Race R., Raines A., Raymond G.J., Caughey B., Chesebro B. Long-term subclinical carrier state precedes scrapie replication and adaptation in a resistant species: analogies to bovine spongiform encephalopathy and variant Creutzfeldt-Jakob disease in humans. J. Virol. 2001, 75(21):10106-10112.
123. Rajendran L., Honsho M., Zahn T.R., Keller P., Geiger K.D., Verkade P., Simons K. Alzheimer's disease β-amyloid peptides are released in association with exosomes. Proc. Natl. Acad. Sci. U. S. A. 2006, 103(30):11172-11177.
124. Raymond G.J., Olsen E.A., Lee K.S., Raymond L.D., Bryant P.K., Baron G.S., Caughey W.S., Kocisko D.A., McHolland L.E., Favara C., Langeveld J.P., van Zijderveld F.G., Mayer R.T., Miller M.W., Williams E.S., Caughey B. Inhibition of protease-resistant prion protein formation in a transformed deer cell line infected with chronic wasting disease. J. Virol. 2006, 80(2):596-604.
125. Raymond G.J., Race B., Hollister J.R., Offerdahl D.K., Moore R.A., Kodali R., Raymond L.D., Hughson A.G., Rosenke R., Long D., Dorward D.W., Baron G.S. Isolation of novel synthetic prion strains by amplification in transgenic mice coexpressing wild-type and anchorless prion proteins. J. Virol. 2012, 86(21):11763-11778.
126. Ritchie A.J., Crawford D.M., Ferguson D.J.P., Burthem J., Roberts D.J. Normal prion protein is expressed on exosomes isolated from human plasma. Br. J. Haematol. 2013, 163(5):678-680.
127. Robertson C., Booth S.A., Beniac D.R., Coulthart M.B., Booth T.F., McNicol A. Cellular prion protein is released on exosomes from activated platelets. Blood 2006, 107(10):3907-3911.
128. Roostaee A., Beaudoin S., Staskevicius A., Roucou X. Aggregation and neurotoxicity of recombinant alpha-synuclein aggregates initiated by dimerization. Mol. Neurodegener. 2013, 8(1):5.
129. Rubenstein R., Carp R.I., Callahan S.M. In vitro replication of scrapie agent in a neuronal model: infection of PC12 cells. J. Gen. Virol. 1984, 65(Pt 12):2191-2198.
130. Rubenstein R., Chang B., Gray P., Piltch M., Bulgin M.S., Sorensen-Melson S., Miller M.W. A novel method for preclinical detection of PrPSc in blood. J. Gen. Virol. 2010, 91(Pt 7):1883-1892.
131. Rubenstein R., Chang B., Gray P., Piltch M., Bulgin M.S., Sorensen-Melson S., Miller M.W. Prion disease detection, PMCA kinetics, and IgG in urine from sheep naturally/experimentally infected with scrapie and deer with preclinical/clinical chronic wasting disease. J. Virol. 2011, 85(17):9031-9038.
132. Saá P., Castilla J., Soto C. Cyclic amplification of protein misfolding and aggregation. Methods Mol. Biol. 2005, 299:53-65.
133. Saá P., Castilla J., Soto C. Presymptomatic detection of prions in blood. Science 2006, 313(5783):92-94.
134. Saá P., Castilla J., Soto C. Ultra-efficient replication of infectious prions by automated protein misfolding cyclic amplification. J. Biol. Chem. 2006, 281(46):35245-35252.
135. Saá P., Sferrazza G.F., Ottenberg G., Oelschlegel A.M., Dorsey K., Lasmezas C.I. Strain-specific role of RNAs in prion replication. J. Virol. 2012, 86(19):10494-10504.
136. Saborio G.P., Permanne B., Soto C. Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature 2001, 411(6839):810-813.
137. Safar J., Wille H., Itri V., Groth D., Serban H., Torchia M., Cohen F.E., Prusiner S.B. Eight prion strains have PrP(Sc) molecules with different conformations. Nat. Med. 1998, 4(10):1157-1165.
138. Safar J.G., Wille H., Geschwind M.D., Deering C., Latawiec D., Serban A., King D.J., Legname G., Weisgraber K.H., Mahley R.W., Miller B.L., DeArmond S.J., Prusiner S.B. Human prions and plasma lipoproteins. Proc. Natl. Acad. Sci. U. S. A. 2006, 103(30):11312-11317.
139. Salvadores N., Shahnawaz M., Scarpini E., Tagliavini F., Soto C. Detection of misfolded Aβ oligomers for sensitive biochemical diagnosis of Alzheimer's disease. Cell Rep. 2014, 7(1):261-268.
140. Saman S., Kim W., Raya M., Visnick Y., Miro S., Saman S., Jackson B., McKee A.C., Alvarez V.E., Lee N.C.Y., Hall G.F. Exosome-associated Tau Is secreted in tauopathy models and is selectively phosphorylated in cerebrospinal fluid in early Alzheimer disease. J. Biol. Chem. 2012, 287(6):3842-3849.
141. Sandberg M.K., Al-Doujaily H., Sigurdson C.J., Glatzel M., O'Malley C., Powell C., Asante E.A., Linehan J.M., Brandner S., Wadsworth J.D., Collinge J. Chronic wasting disease prions are not transmissible to transgenic mice overexpressing human prion protein. J. Gen. Virol. 2010, 91(Pt 10):2651-2657.
142. Saunders S.E., Bartz J.C., Shikiya R.A. Protein misfolding cyclic amplification of prions. J. Vis. Exp. 2012, (69).
143. Schiermeier Q. Testing times for BSE. Nature 2001, 409(6821):658-659.
144. Schneider A., Simons M. Exosomes: vesicular carriers for intercellular communication in neurodegenerative disorders. Cell Tissue Res. 2012, 352(1):33-47.
145. Silveira J.R., Raymond G.J., Hughson A.G., Race R.E., Sim V.L., Hayes S.F., Caughey B. The most infectious prion protein particles. Nature 2005, 437(7056):257-261.
146. Simak J., Holada K., D'Agnillo F., Janota J., Vostal J.G. Cellular prion protein is expressed on endothelial cells and is released during apoptosis on membrane microparticles found in human plasma. Transfusion 2002, 42(3):334-342.
147. Simoneau S., Rezaei H., Sales N., Kaiser-Schulz G., Lefebvre-Roque M., Vidal C., Fournier J.G., Comte J., Wopfner F., Grosclaude J., Schatzl H., Lasmezas C.I. In vitro and in vivo neurotoxicity of prion protein oligomers. PLoS Pathog. 2007, 3(8):e125.
148. Soto C., Anderes L., Suardi S., Cardone F., Castilla J., Frossard M.J., Peano S., Saá P., Limido L., Carbonatto M., Ironside J., Torres J.M., Pocchiari M., Tagliavini F. Pre-symptomatic detection of prions by cyclic amplification of protein misfolding. FEBS Lett. 2005, 579(3):638-642.
149. Soto C., Saborio G.P., Anderes L. Cyclic amplification of protein misfolding: application to prion-related disorders and beyond. Trends Neurosci. 2002, 25(8):390-394.
150. Surgucheva I., Sharov V.S., Surguchov A. γ-Synuclein: seeding of α-synuclein aggregation and transmission between cells. Biochemistry 2012, 51(23):4743-4754.
151. Tamguney G., Giles K., Bouzamondo-Bernstein E., Bosque P.J., Miller M.W., Safar J., DeArmond S.J., Prusiner S.B. Transmission of elk and deer prions to transgenic mice. J. Virol. 2006, 80(18):9104-9114.
152. Taraboulos A., Serban D., Prusiner S.B. Scrapie prion proteins accumulate in the cytoplasm of persistently infected cultured cells. J. Cell Biol. 1990, 110(6):2117-2132.
153. Tasaki M., Ueda M., Ochiai S., Tanabe Y., Murata S., Misumi Y., Su Y., Sun X., Shinriki S., Jono H., Shono M., Obayashi K., Ando Y. Transmission of circulating cell-free AA amyloid oligomers in exosomes vectors via a prion-like mechanism. Biochem. Biophys. Res. Commun. 2010, 400(4):559-562.
154. Tattum M.H., Jones S., Pal S., Collinge J., Jackson G.S. Discrimination between prion-infected and normal blood samples by protein misfolding cyclic amplification. Transfusion 2010, 50(5):996-1002.
155. Telling G.C., Parchi P., DeArmond S.J., Cortelli P., Montagna P., Gabizon R., Mastrianni J., Lugaresi E., Gambetti P., Prusiner S.B. Evidence for the conformation of the pathologic isoform of the prion protein enciphering and propagating prion diversity. Science 1996, 274(5295):2079-2082.
156. Thery C.C.A., Amogorena S., Raposo G. Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr. Protoc. Cell Biol. John Wiley and Sons, Inc. 2006.
157. Thorne L., Terry L.A. In vitro amplification of PrPSc derived from the brain and blood of sheep infected with scrapie. J. Gen. Virol. 2008, 89(Pt 12):3177-3184.
158. Timmes A.G., Moore R.A., Fischer E.R., Priola S.A. Recombinant prion protein refolded with lipid and RNA has the biochemical hallmarks of a prion but lacks in vivo infectivity. PLoS ONE 2013, 8(7):e71081.
159. Veith N.M., Plattner H., Stuermer C.A., Schulz-Schaeffer W.J., Burkle A. Immunolocalisation of PrPSc in scrapie-infected N2a mouse neuroblastoma cells by light and electron microscopy. Eur. J. Cell Biol. 2009, 88(1):45-63.
160. Vella L.J., Sharples R.A., Lawson V.A., Masters C.L., Cappai R., Hill A.F. Packaging of prions into exosomes is associated with a novel pathway of PrP processing. J. Pathol. 2007, 211(5):582-590.
161. Vidal E., Fernandez-Borges N., Pintado B., Ordonez M., Marquez M., Fondevila D., Torres J.M., Pumarola M., Castilla J. Bovine spongiform encephalopathy induces misfolding of alleged prion-resistant species cellular prion protein without altering its pathobiological features. J. Neurosci.: Off. J. Soc. Neurosci. 2013, 33(18):7778-7786.
162. Vilette D., Andreoletti O., Archer F., Madelaine M.F., Vilotte J.L., Lehmann S., Laude H. Ex vivo propagation of infectious sheep scrapie agent in heterologous epithelial cells expressing ovine prion protein. Proc. Natl. Acad. Sci. U. S. A. 2001, 98(7):4055-4059.
163. Vingtdeux V., Sergeant N., Buee L. Potential contribution of exosomes to the prion-like propagation of lesions in Alzheimer's disease. Front. Physiol. 2012, 3.
164. †. Biochemistry 2003, 42(26):7871-7878.
165. Volpicelli-Daley L.A., Luk K.C., Patel T.P., Tanik S.A., Riddle D.M., Stieber A., Meaney D.F., Trojanowski J.Q., Lee V.M.Y. Exogenous α-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death. Neuron 2011, 72(1):57-71.
166. Wadsworth J.D., Dalmau-Mena I., Joiner S., Linehan J.M., O'Malley C., Powell C., Brandner S., Asante E.A., Ironside J.W., Hilton D.A., Collinge J. Effect of fixation on brain and lymphoreticular vCJD prions and bioassay of key positive specimens from a retrospective vCJD prevalence study. J. Pathol. 2011, 223(4):511-518.
167. Wang F., Wang X., Yuan C.G., Ma J. Generating a prion with bacterially expressed recombinant prion protein. Science 2010, 327(5969):1132-1135.
168. Wang F., Zhang Z., Wang X., Li J., Zha L., Yuan C.G., Weissmann C., Ma J. Genetic informational RNA is not required for recombinant prion infectivity. J. Virol. 2012, 86(3):1874-1876.
169. Weber P., Giese A., Piening N., Mitteregger G., Thomzig A., Beekes M., Kretzschmar H.A. Cell-free formation of misfolded prion protein with authentic prion infectivity. Proc. Natl. Acad. Sci. U. S. A. 2006, 103(43):15818-15823.
170. Weber P., Giese A., Piening N., Mitteregger G., Thomzig A., Beekes M., Kretzschmar H.A. Generation of genuine prion infectivity by serial PMCA. Vet. Microbiol. 2007, 123(4):346-357.
171. Weber T., Otto M., Bodemer M., Zerr I. Diagnosis of Creutzfeldt-Jakob disease and related human spongiform encephalopathies. Biomed. Pharmacother. 1997, 51(9):381-387.
172. Weissmann C. A 'unified theory' of prion propagation. Nature 1991, 352:679-683.
173. Weissmann C. Birth of a prion: spontaneous generation revisited. Cell 2005, 122(2):165-168.
174. Wik L., Klingeborn M., Willander H., Linne T. Separate mechanisms act concurrently to shed and release the prion protein from the cell. Prion 2012, 6(5):498-509.
175. Williams E.S.Y.S. Chronic wasting disease of captive mule deer: a spongiform encephalopathy. J. Wildl. Dis. 1980, 16(1):89-98.
176. Wilson R., Plinston C., Hunter N., Casalone C., Corona C., Tagliavini F., Suardi S., Ruggerone M., Moda F., Graziano S., Sbriccoli M., Cardone F., Pocchiari M., Ingrosso L., Baron T., Richt J., Andreoletti O., Simmons M., Lockey R., Manson J.C., Barron R.M. Chronic wasting disease and atypical forms of bovine spongiform encephalopathy and scrapie are not transmissible to mice expressing wild-type levels of human prion protein. J. Gen. Virol. 2012, 93(Pt 7):1624-1629.
177. Windl O., Dawson M. Animal prion diseases. Sub-cell. Biochem. 2012, 65:497-516.
178. Yuan J., Xiao X., McGeehan J., Dong Z., Cali I., Fujioka H., Kong Q., Kneale G., Gambetti P., Zou W.Q. Insoluble aggregates and protease-resistant conformers of prion protein in uninfected human brains. J. Biol. Chem. 2006, 281(46):34848-34858.
179. Zhang Z., Zhang Y., Wang F., Wang X., Xu Y., Yang H., Yu G., Yuan C., Ma J. De novo generation of infectious prions with bacterially expressed recombinant prion protein. Off. Publ. Fed. Am. Soc. Exp. Biol.: FASEB J. 2013, 27(December (12)):4768-4775.